Cathay Biotech

Cathay Biotech FCF/Debt

The Free Cash Flow to Debt Ratio of Cathay Biotech (688065.SS) as of Nov 17, 2026 is -179.58 %. In the previous year, Free Cash Flow to Debt Ratio was -1.20 % — a change of 14,823.45% (lower).

FCF/Debt

-179.58 %

YoY

14,823.45%

Last updated:

Free Cash Flow to Debt Ratio of Cathay Biotech is 2025 -179.58 % . Free Cash Flow to Debt Ratio of Cathay Biotech was 2024 -1.20 % . It decreases by 14,823.45% lower compared to the previous year.

The Cathay Biotech FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
-1,221.69 CNY
Jan 1, 2018
-328.42 CNY
Jan 1, 2019
-50.47 CNY
Jan 1, 2021
-118.42 CNY
Jan 1, 2022
-301.12 CNY
Jan 1, 2023
-56.33 CNY
Jan 1, 2024
-1.20 CNY
Jan 1, 2025
-179.58 CNY
The Cathay Biotech FCF/Debt history
YEARFCF/DebtYoY
-179.58 %+14,823.45%
-1.20 %-97.86%
-56.33 %-81.29%
-301.12 %+154.27%
-118.42 %+134.66%
-50.47 %-84.63%
-328.42 %-73.12%
-1,221.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cathay Biotech Stock analysis

What does Cathay Biotech do? Cathay Biotech Inc. generates revenue through the research and development, production, and sales of new bio-based materials. The firm's primary offerings include biological long-chain dibasic acids and bio-based polyamide series, such as lauric acid and brazilian acid. These products serve various industrial applications, including long-chain polyamides, fragrances, hot melt adhesives, lubricants, and powder coatings. The company distributes its products to both domestic and overseas markets. This global reach allows Cathay Biotech Inc. to capture value from a broad customer base across different regions. The business model relies on the continuous development and commercialization of these specialized bio-based chemical solutions. Cathay Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cathay Biotech stock

Free Cash Flow to Debt Ratio of Cathay Biotech is -179.58 % in 2025.

Free Cash Flow to Debt Ratio of Cathay Biotech changed from -1.20 % to -179.58 %, representing a 14,823.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Cathay Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Cathay Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cathay Biotech

All Key Metrics — Cathay Biotech